#biotech (2 Posts)
-
U.S. Congress Fails to Pass Biosecurity Act, WuXi Biologics Resumes Plant Construction The U.S. Congress has failed to pass the Biosecurity Act this year, a bill aimed at countering Chinese biotech firms. -
U.S. and Allies to Discuss High-Tech Bio Collaboration and Chinese Competition High-ranking officials from South Korea, the United States, Japan, and India are set to convene at BIO USA 2024 to discuss strategies for advancing the industry. The summit will mainly address critical issues such as strengthening pharmaceutical supply chains but it may also touch upon the U.S.’s efforts to counter the influence of Chinese biotech […]
Hot Topics